Furthermore, we used TCGA and CGGA databases to analyze the survival probability of glioma patients with different expression levels of SIGLEC9. In TCGA dataset, patients with a higher SIGLEC9 expression had less survival probability than patients with a lower SIGLEC9 expression (P < 0.001) (Figure 2A). The gene discussed is SIGLEC9; the disease is central nervous system cancer.